FDA Inspection 1321998 — Vitalant

Vitalant — FEI 2077857

The FDA completed an inspection of Vitalant on May 19, 2026 in Chandler, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 19, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Chandler, AZ (United States)